2020年12月1日 · Therapies, including levodopa, have not demonstrated the ability to slow disease progression. Motor symptoms are managed with carbidopa/levodopa, monoamine oxidase-B inhibitors, and nonergot...

2021年11月15日 · To relieve these early symptoms, treatment options include dopaminergic medications, drugs that increase dopamine levels or mimic dopamine effects.

Healthcare professionals may recommend regular follow-up appointments with neurologists trained in movement disorders to evaluate your condition and symptoms over time and diagnose Parkinson's disease. Your healthcare team may order some of these tests and procedures: Physical and neurological exam.

The treatment of Parkinson's disease (PD) is challenging, especially since it is considered highly individualized. The Brazilian Academy of Neurology has recognized the need to disseminate knowledge about the management of PD treatment, adapting the best evidence to …

This guideline covers diagnosing and managing Parkinson’s disease in people aged 18 and over. It aims to improve care from the time of diagnosis, including monitoring and managing symptoms, providing information and support, and palliative care.

2024年11月4日 · In this Review, we examine the current state of research into PD therapies and outline future priorities for advancing our understanding and treatment of the disease.

Treatment of advanced PD, particularly the complications associated with long-term levodopa therapy, and management of the comorbid problems including daytime sleepiness, hallucinations, and psychosis are reviewed elsewhere.

This guideline covers diagnosing and managing Parkinson’s disease in people aged 18 and over. It aims to improve care from the time of diagnosis, including monitoring and managing symptoms, providing information and support, and palliative care.

Initial treatment of early Parkinson disease (PD) with levodopa provides greater benefit for motor symptoms than initial treatment with dopamine agonists, as shown in the majority of studies that

Current evidence is strongest for interventions targeting people with early to mid-stage Parkinson disease. The Parkinson disease CPG identifies the outcomes that have been shown to improve in relation to a series of interventions and treatment approaches. Published January 2022 in Physical Therapy & Rehabilitation Journal.